Fertility treatment is something most people know exists but few understand in detail until they need it. The gap between what people expect and what IVF actually involves – the monitoring, injections, egg collection procedure, waiting, and variable outcomes – is one of the reasons the experience is often harder than anticipated.
This article aims to provide an honest, accurate account of the fertility treatment landscape in the UK: what IVF involves, what success rates actually mean, what the NHS offers and where, and what the experience is likely to look like for couples going through it.
Healthbooq (healthbooq.com/apps/healthbooq-kids) covers fertility and reproductive health.
Who Needs Fertility Treatment
Around 1 in 7 couples in the UK experience difficulty conceiving. The causes divide roughly equally between female factors, male factors, and unexplained subfertility. Female factors include ovulatory dysfunction (polycystic ovary syndrome, premature ovarian insufficiency), blocked fallopian tubes (often from previous infection or endometriosis), and reduced ovarian reserve with age. Male factors are primarily sperm quality issues – concentration, motility, morphology – with severe cases, including azoospermia (no sperm in the ejaculate), requiring specialist management.
Unexplained subfertility accounts for around 25-30% of cases: all investigations return normal results, yet pregnancy doesn't occur. This is a frustrating category because it doesn't point to an obvious treatment target, though IUI (intra-uterine insemination) and IVF can improve outcomes by overcoming biological barriers that aren't detectable by standard tests.
IUI: Intrauterine Insemination
IUI is the simplest form of assisted conception: sperm (prepared in the laboratory by washing and concentrating the most motile cells) are placed directly into the uterus around the time of ovulation, either in a natural cycle or in a mildly stimulated cycle. It bypasses the cervix and places sperm closer to the fallopian tubes, which may improve conception rates where cervical mucus or sperm motility is mildly suboptimal.
Success rates for IUI are modest: around 10-15% per cycle for couples with unexplained subfertility or mild male factor. NICE recommends three cycles of IUI before moving to IVF for couples with unexplained subfertility. NHS provision for IUI is limited and inconsistent.
IVF: What It Involves
IVF (in-vitro fertilisation) involves stimulating the ovaries to produce multiple eggs, retrieving those eggs transvaginally under sedation, fertilising them with sperm in the laboratory, culturing the resulting embryos for 3-5 days, and then transferring one (occasionally two) embryo into the uterus.
The stimulation phase (typically 10-14 days) involves daily injections of gonadotrophins (follicle-stimulating hormone, FSH) to stimulate multiple follicle development. This is monitored with repeated ultrasound scans and sometimes blood tests to track follicle growth. When follicles reach the right size, a trigger injection (hCG or a GnRH agonist) matures the eggs.
Egg collection happens 34-36 hours after the trigger. It is a minor surgical procedure done under conscious sedation: a needle is passed transvaginally under ultrasound guidance into each follicle, and the fluid (and ideally the egg it contains) is aspirated. Most clinics collect between 8 and 15 eggs; the number depends on ovarian reserve and stimulation response.
In the laboratory, eggs are fertilised with sperm either by standard insemination (mixing eggs and sperm) or by ICSI (intra-cytoplasmic sperm injection, where a single sperm is injected directly into each egg). ICSI is used when sperm quality is significantly reduced. Not all fertilised eggs develop into embryos; typically around 60-70% of mature eggs fertilise and around 30-50% progress to day-5 blastocyst stage.
Embryo transfer involves placing one embryo (in most NHS cycles) through the cervix into the uterus using a thin catheter. Additional embryos can be frozen for future transfer cycles.
Ovarian hyperstimulation syndrome (OHSS) is the main medical risk of IVF: the ovaries over-respond to stimulation, becoming enlarged and painful, with fluid accumulation. Mild OHSS is common and self-limiting; severe OHSS (requiring hospitalisation) occurs in around 1-2% of IVF cycles and is more common in young women with polycystic ovaries. OHSS protocols have improved significantly: using antagonist protocols and GnRH agonist triggers reduces OHSS risk considerably, and freeze-all cycles (freezing all embryos for later transfer rather than fresh transfer) are used for those at highest risk.
Success Rates and What They Mean
The HFEA (Human Fertilisation and Embryology Authority) publishes outcome data for all UK licensed clinics and for the sector as a whole. Its 2022 data shows overall live birth rates per embryo transfer of approximately:
Age under 35: 32-35%
Age 35-37: 25-28%
Age 38-39: 17-20%
Age 40-42: 9-12%
Age 43-44: 4-6%
Age 45+: around 1-2% using own eggs
These are per-transfer rates, not per-cycle-started: some cycles do not result in an egg collection, and some do not result in an embryo to transfer. Cumulative success rates (counting fresh and all subsequent frozen embryo transfers from a single stimulation cycle) are higher.
The figures for donor egg IVF are substantially higher because the donor is typically a young woman with good ovarian reserve: live birth rates of around 45-50% per transfer for donor egg cycles regardless of recipient age.
NHS Access and the Postcode Lottery
NHS provision of IVF in England has become one of the starkest examples of geographic health inequality. NICE guidelines recommend three full cycles of IVF for eligible women under 40 (and one cycle for women 40-42) who have been trying for two years. In practice, many NHS commissioning groups in England offer nothing, or only one cycle, and eligibility criteria (BMI requirements, prior children, relationship status) vary enormously between areas.
Scotland, Wales, and Northern Ireland have more consistent provision. The HFEA's Fertility Treatment UK trend data consistently shows that the majority of IVF cycles in the UK are NHS-funded, but the distribution is highly uneven.
For those who need private treatment, the cost of a single IVF cycle in the UK ranges from around £3,000 to £6,000, not including the cost of medications (typically £1,000-£2,000 per cycle). The variation in clinic pricing, and the variable add-ons that clinics offer at additional cost (many of which are not evidence-based), make it difficult to compare costs directly. The HFEA publishes a guide to treatment add-ons and their evidence status.
The Emotional Dimension
IVF is physically demanding and emotionally exhausting. The two-week wait between embryo transfer and pregnancy test is a period of intense uncertainty; the news either way arrives with a force that people who haven't been through the process tend to underestimate. Failed cycles are genuine losses, and the cumulative effect of multiple cycles – whether or not they succeed – takes a psychological toll.
NICE recommends that couples undergoing fertility treatment should be offered counselling at all stages of treatment. In practice, access to counselling within NHS fertility clinics is variable. The charity Fertility Network UK provides peer support, a helpline, and local support groups for those going through fertility treatment.
Key Takeaways
Around 1 in 7 couples in the UK will need some form of fertility treatment. In-vitro fertilisation (IVF) is the most effective fertility treatment available, with live birth rates per cycle of around 25-35% for women under 35, declining with age. IVF is available on the NHS but access is highly variable across England, with some Clinical Commissioning Groups offering three cycles and others offering none; Scotland, Wales and Northern Ireland have more consistent provision. The Human Fertilisation and Embryology Authority (HFEA) regulates all fertility treatments in the UK and publishes clinic success rates. The physical and emotional demands of IVF are significant and often underestimated.
